Loxo Oncology, Inc.
Clinical trials sponsored by Loxo Oncology, Inc., explained in plain language.
-
New leukemia pill goes Head-to-Head with standard treatment in major trial
Disease control Recruiting nowThis study aims to compare the effectiveness and safety of a new oral drug called pirtobrutinib against the standard drug ibrutinib for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). It will enroll about 660 participants, some who have had pri…
Phase: PHASE3 • Sponsor: Loxo Oncology, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for leukemia patients when standard treatments stop working
Disease control Recruiting nowThis study is testing three different doses of an experimental drug called pirtobrutinib for people with chronic lymphocytic leukemia or small lymphocytic lymphoma whose cancer has returned or worsened after previous treatment with a specific type of medication called a BTK inhib…
Phase: PHASE2 • Sponsor: Loxo Oncology, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC